KH-1
Asset
Dietary polyamine supplement intended to stimulate autophagy
- Stage
- Human trials
- Modality
- Supplement
- Target
- Autophagy
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Aging
Human trials, Completed, NCT06445569, clinicaltrials.gov, 7 Oct 2026
Prediabetes
Human trials, Completed, NCT06445569, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors8
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.